MedPath

Treatment of anxiety disorders in children with Autism Spectrum Disorders (ASD).

Completed
Registration Number
NL-OMON22241
Lead Sponsor
niversity of Amsterdam Participants are recruited by several mental health centers across the Netherlands
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

1. Children, aged 7-18, must have at least one anxiety disorder (all anxiety disorder are included), according to parent and/or child report;

2. At least one parent is willing to participate in treatment and research.

Exclusion Criteria

1. Acute suicidal behavior;

2. Untreated psychotic disorder;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Diagnostic status: whether the child still meets criteria for its (primary) anxiety disorder (ADIS);<br /><br>2. Anxiety symptomatology (SCARED);<br /><br>3. Quality of Life (QoL; EQ-5D);<br /><br>4. Costs (measured by a retrospective costs-questionnaire).
Secondary Outcome Measures
NameTimeMethod
1. General psychopathology (CBCL);<br /><br>2. ASD-related symptoms (CSBQ);<br /><br>3. Family Functioning (FFS & FAST);<br /><br>4. Parental rearing behavior (CDQ);<br /><br>5. Parental anxiety (SCARED);<br /><br>6. Parental quality of life (EuroQol);<br /><br>7. Attachment (AQ).
© Copyright 2025. All Rights Reserved by MedPath